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INTRODUCTION
Before deciding to initiate chronic dialysis in a patient
with chronic renal failure, both the physician and patient
must consider the subjective and objective parameters.
The indications for the initiation of dialysis in chronic
kidney disease (CKD) include pericarditis or pleuritis,
progressive uremic encephalopathy or neuropathy,
clinically significant uremic bleeding diathesis, and
malnutrition and fluid overload refractory to diuretics.
Persistent metabolic disturbances that are refractory to
medical therapies are among the most important
indications. However, in cases with no clinical or meta-
bolic disturbances, the time point for initiating dialysis
remains controversial.
Some guidelines recommend that dialysis be initiated
when the estimated glomerular filtration rate (eGFR) falls
below the recommended level in asymptomatic CKD
patients. In Canada, clinical practice guidelines recommend
starting dialysis when the GFR is <12 mL/min/1.73m
2 in
the presence of uremia or malnutrition, or when the GFR
is <6 mL/min/1.73m
2 regardless of whether the case is
symptomatic or asymptomatic [1]. Earlier guidelines
outlined by the National Kidney Foundation in the
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renal replacement therapy (RRT) be considered when the
GFR falls below 10.5 mL/min/1.73m
2 [2]. In their more
recent 2006 update, the National Kidney Foundation
recommends that nephrologists evaluate the risks and
benefits of initiating dialysis when patients reach stage 5
CKD [3].
Despite these guidelines, there exists a wide variation
in the time point selected for the initiation of chronic
hemodialysis based on levels of residual renal function,
and many patients continue to be treated with dialysis
when having a very low GFR. Short-term study results on
the benefits and risks of both early and late initiation of
dialysis in an asymptomatic patient with CKD have been
obtained, but long-term results have yet to be reported.
Accordingly, we conducted a retrospective study to deter-
mine the relationship between mortality and GFR at the
initiation of dialysis in patients with CKD.
METHODS
Patients who were admitted to the hospital for the
initiation of RRT between 1 January 2000 and 31 June
2005 were enrolled in the study. Of these, patients with
acute renal failure and those who had recovered renal
function were excluded. Follow-up was continued until 31
June 2007.
The baseline data collected included age, gender, and
the cause of renal failure. The most prominent symptom
or the indication prompting the initiation of dialysis
therapy was also noted.
For all study subjects, the decision to initiate dialysis
was made by an attending nephrologist. Pre-dialysis blood
urea nitrogen (BUN), serum creatinine, and serum albu-
min concentrations, as well as estimated GFR calculated
by the Modification of Diet in Renal Disease (MDRD)
equation, were measured once before the first dialysis.
The high and low estimated GFRs were defined as values
more than and less than 5 mL/min/1.73m
2. Deaths during
follow-up were noted, and the cause of mortality was
obtained from death certificates.
Survival duration was defined as the period from the
initiation of chronic dialysis to death. Hospitalization
refers to the admission frequency after the initiation of
chronic dialysis, except for hospitalization due to trauma.
Mortality analyses were performed using Kaplan-Meier
survival curves, with survival rates during the follow-up
estimated for patients in the various groups. Survival
curves were compared between groups using the log-rank
test, and differences were considered statistically signi-
ficant for pvalues<0.05.
RESULTS
A total of 210 patients who began dialysis because of
chronic kidney disease were recruited in the study. Of
these, 108 (51.4%) were hemodialysis patients and 102
(48.6%) were peritoneal dialysis patients. There were 69
men (32.9%) and 141 women (67.1%); the mean age was
50.4±14.9 years. The mean serum creatinine and BUN
levels were 11.8±12.3 mg/dL and 92.6±36.4 mg/dL,
respectively. The mean eGFR calculated using a four-
variable MDRD equation was 5.8±3.3 mL/min/1.73m
2,
and the mean survival period was 37.3±17.7 months.
The study subjects were grouped based on eGFR at
the initiation of dialysis. Ninety-nine patients had an
eGFR<5 mL/min/1.73m
2; their mean eGFR was 3.4±1.1
mL/min/1.73m
2, and their mean age was 47.6±13.9 years.
Of the 99 patients, 47 (47.5%) were hemodialysis patients
and 52 (52.5%) were peritoneal dialysis patients. Their
mean albumin level was 3.09±0.71 g/dL, and the mean
survival duration was 35.0±18.2 months (Table 1).
In the group with an eGFR>5 mL/min/1.73m
2, there
were 111 (52.8%) patients: 61 hemodialysis patients
(54.9%) and 50 peritoneal dialysis patients (45.1%). Their
mean eGFR was 8.0±3.0 mL/min/1.73m
2, and their mean
age was 52.9±15.3 years. Their mean serum albumin level
was 3.13±0.69 g/dL (Table 1).
Classified based on the modality of RRT, the hemodialy-
sis group had a mean age of 56.1±14.3 years, a mean eGFR
of 6.0±3.3 mL/min/1.73m
2, a mean albumin level of
3.03±0.68 g/dL, and a mean survival duration of
33.2±17.1 months. For the peritoneal dialysis patients, the
mean age was 44.4±13.1 years, the mean eGFR was
5.6±3.3 mL/min/1.73m
2, and the mean survival duration
was 41.1±17.5 months (Table 2).
The reasons for initiating RRT were high serum cre-
atinine and/or BUN levels (n=66, 31.4%); volume over-
load (n=51, 24.3%); uremic symptoms such as nausea,
vomiting, poor appetite, or encephalopathy (n=86, 41%);
or electrolyte imbalances (n=7, 3.3%). Emergency RRT
was performed in 136 (64.8%) patients, primarily for
symptoms of uremia (n=62, 45.6%) (Table 3). There were
no differences between the asymptomatic and symp-
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3.08±0.70 g/dL; p=0.993), eGFR (6.2±3.1 vs. 5.7±3.3
mL/min/1.73m
2, p=0.149), and survival duration
(37.2±20.1 vs. 37.3±16.8 months, p=0.236) (Table 4). 
A total of 33 patients died during the follow-up period;
11 (33.3%) of these expired due to cardiovascular causes.
Other causes of death included infection (n=7, 21.2%),
malignancy (n=3, 9%), bleeding (n=3, 9%), other causes
(i.e., seizures, suicide, gastrointestinal perforation, and
traffic accident; n=4), and unknown causes (n=5, 15.1%)
(Table 5).
According to the Kaplan-Meier survival curves,
hemodialysis patients had poorer survival rates than
peritoneal dialysis patients (p=0.002). There was no
difference in survival between the groups based on eGFRs
at the initiation of dialysis (p=0.27). Furthermore, there
were no differences in survival based on the indications
for starting RRT or whether emergency RRT was
performed (Fig. 1). However, in the subgroup analysis,
the hemodialysis patients with higher eGFRs (>5
mL/min/1.73 m
2) at the initiation of dialysis showed
higher survival rates compared with those with lower
eGFRs (<5 mL/min/1.73m
2) at initiation (Fig. 2). In addi-
tion, among these patients, there was no significant
difference in survival between the diabetic and non-
diabetic patients. In the peritoneal dialysis patient group,
there was no significant difference in survival between
those with higher and those with lower eGFRs; however,
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Table 1. Basic characteristics of patients classified by estimated glomerular filtration rate
Characteristic Total GFR<5 mL/min GFR≥5 mL/min p value
(n=210) (n=99) (n=111)
Gender (M:F) 69:141 21:78 48:63 ND 
Age (yr) 50.4±14.9 47.6±13.9 52.9±15.3 0.009
HD:PD 108:102 47:52 61:50 ND
DM:Non-DM 99:111 36:63 64:47 0.002
Serum Creatinine (mg/dL) 11.8±12.3 16.9±16.4 7.2±1.8 ≤0.001
BUN (mg/dL) 92.6±36.4 110.7±39.6 76.5±23.9 ≤0.001
Serum albumin (g/dL) 3.11±0.70 3.09±0.71 3.13±0.69 0.633
Estimated GFR (mL/min/1.73m
2) 5.8±3.3 3.4±1.1 8.0±3.0 ≤0.001
Survival duration (month) 37.3±17.7 35.0±18.2 39.4±17.0 0.096
Hospitalization (day) 1.7±2.0 1.6±2.2 1.8±1.8 0.340
GFR, glomerular filtration rate; ND, not done; HD, hemodialysis; PD, peritoneal dialysis; DM, diabetes mellitus.
Table 2. Basic characteristics of patients receiving renal replacement therapy
Characteristic Total HD PD p value
Gender (Male, number) 69 31 38 ND   
Age (yr) 50.4±14.9 56.1±14.3 44.4±13.1 ≤0.001
DM (number) 99 63 37 0.001
Serum Creatinine (mg/dL) 11.8±12.3 11.8±16.2 11.7±6.0 0.964
BUN (mg/dL) 92.6±36.4 86.5±36.0 99.1±35.9 0.012
Serum albumin (g/dL) 3.11±0.70 3.03±0.68 3.20±0.71 0.080
Estimated GFR (mL/min/1.73m
2) 5.8±3.3 6.0±3.3 5.1±3.3 0.330
Survival duration (month) 37.3±17.7 33.2±17.1 41.1±17.5 0.003
Hospitalization (day) 1.7±2.0 1.2±1.8 2.2±2.1 ≤0.001
GFR, glomerular filtration rate; ND, not done; HD, hemodialysis; PD, peritoneal dialysis; DM, diabetes mellitus.
Table 3. The causes of the initiation of dialysis
Cause
Non-emergency RRT Emergency RRT
(n=74) (n=136)
High RFT 41 (55.4%) 25 (18.4%)
Volume overload 9 (12.2%) 42 (30.9%)
Uremic symptoms 24 (32.4%) 62 (45.6%)
Electrolyte imbalance 0 (0%) 7 (5.1%)
RRT, renal replacement therapy; RFT, renal function test (serum creatinine and/or BUN).the diabetic patients had significantly lower survival rates
than the non-diabetic patients (Fig. 4).
There was no significant difference in survival between
the patient groups with and without emergency RRT. The
survival rates in hemodialysis and peritoneal dialysis
patients did not differ regardless of the cause for initiating
RRT (Fig. 3).
DISCUSSION
The decision to initiate dialysis in end-stage renal
disease is not an easy one for either patients or physicians.
The main reasons for initiating chronic dialysis are
symptoms relating to reduced renal function, including
nausea, vomiting, poor appetite, over-hydration,
encephalopathy, and electrolyte imbalance. Some
guidelines recommend that chronic dialysis be initiated
at a specified eGFR. However, in patients with chronic
renal failure, the clinical features and laboratory indices
that are used as guidelines for initiating RRT do not
always correlate with survival [4]. Our study revealed that
the survival of patients did not depend on the indications
used in deciding to initiate chronic dialysis. For example,
patients who underwent chronic dialysis because of high
serum creatinine and/or BUN levels did not have better
survival rates than patients who underwent chronic dialy-
sis for symptoms related to uremia, volume overload, or
electrolyte imbalances.
In several reports and guidelines, the baseline eGFR
used to initiate early dialysis ranges from 5 to 15 mL/min
[5]. In the present study, the criterion used to define the
high eGFR group was an eGFR>5 mL/min.
The suggestion that early initiation of dialysis is
beneficial was first supported by Bonomini et al. [6]. The
Canada-USA (CANUSA) study reported significantly
poorer survival rates for patients with lower levels of
residual renal function at the initiation of dialysis [7];
similar results were found by Tattersall et al. [8]. Other
studies, however, failed to take into account the effect of
lead-time bias. Jamie et al. reported that a Cox pro-
portional hazards model demonstrated a significant
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Table 4. Basic characteristics of patients classified by the cause of the initiation of dialysis
Characteristic Total High RFT Symptomatic p value
Age (yr) 50.4±14.9 49.5±14.3 50.8±15.1 0.339
Serum Creatinine (mg/dL) 11.8±12.3 9.3±3.4 12.7±14.3 0.029
BUN (mg/dL) 92.6±36.4 85.2±29.0 95.6±38.7 0.057
Serum albumin (g/dL) 3.11±0.70 3.19±0.71 3.08±0.70 0.993
Estimated GFR (mL/min/1.73m
2) 5.8±3.3 6.2±3.1 5.7±3.3 0.149
Survival duration (month) 37.3±17.7 37.2±20.1 37.3±16.8 0.236
Hospitalization (day) 1.7±2.0 1.9±2.0 1.6±2.0 0.565
RFT, renal function test (serum creatinine and/or BUN); GFR, glomerular filtration rate.
Table 5. Causes of death
Modality of RRT* Estimated GFR
Cause Total HD PD <5 mL/min/1.73m
2 ≥5 mL/min/1.73m
2
(n=33) (n=23) (n=10) (n=18) (n=15)
Vascular 11  (33.3) 7 4 8 2
Cerebrovascular 3 2 4 2 1
Cardiovascular 7 4 3 6 1
AVF rupture  1 1 0 0 1
Infection 7  (21.2) 6 1 4 3
Malignancy 3  (9.0) 2 1 2 1
Bleeding 3  (9.0) 2 1 1 2
Other 4  (12.1) 3 1 3 1
Seizure 1 0 1 0 1
Suicide 1 1 0 1 0
Pneumoperitoneum 1 1 0 1 0
TA 1 1 0 1 0
Unknown 5 (15.1) 3 2 0 5
RRT, renal replacement therapy; GFR, glomerular filtration rate; TA, traffic accident.Kim SG and Kim NH. Residual renal function at the initiation of dialysis and patient survival   59
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Figure 1. Kaplan-Meier survival curves. Hemodialysis patients showed higher mortality rates than peritoneal dialysis patients (p=0.02, A); there were no
significant differences in survival between patients according to estimated GFR (p=0.27, B), emergency dialysis (p=0.08, C), or symptoms (p=0.93, D).
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Figure 2. Kaplan-Meier survival curves. There were higher mortality rates for hemodialysis patients compared with peritoneal dialysis patients in the
lower estimated GFR group (p<0.01, A); however, there were no differences in the higher estimated GFR group (p=0.384, B). Hemodialysis patients with
lower estimated GFR had higher mortality rates than hemodialysis patients with higher estimated GFR (p<0.05, C); however, there were no differences
for peritoneal dialysis patients (p=0.50, D).
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Figure 3. Kaplan-Meier survival curves. There was no significant survival difference between the groups receiving emergency RRT and those receiving
non-emergency RRT (A and B) in either the hemodialysis (p=0.184, A) or the peritoneal dialysis patients (p=0.712, B). The survival rates in neither the
hemodialysis (p=0.78, C) nor the peritoneal dialysis (p=0.315, D) groups differed based on the cause for initiating RRT.
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Figure 4. Kaplan-Meier survival curves. Overall, diabetic patients
showed lower survival rates compare with non-diabetic patients
(p<0.01, A). Diabetic patients also showed lower survival rates in the
peritoneal dialysis group (p=0.01, C), but there were no significant
differences in survival rates between diabetic and non-diabetic patients
in the hemodialysis group (p=0.12, B).
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Cinverse relationship between the estimated creatinine
clearance rate at the start of dialysis and survival, so that
patients who started dialysis with lower estimated
creatinine clearance rates tended to survive longer [8].
This relationship became significant when parameters
such as gender, age, weight, presence of diabetes, mode of
first dialysis, initial dialysis access, hemoglobin level,
serum albumin level, blood leukocyte count, and Wright
/Khan index were taken into account at the start of dialysis.
The major causes of death in patients undergoing
dialysis are cardiovascular disease, infection, and with-
drawal from treatment [10]. In general, cardiovascular
disease accounts for approximately 50% of the deaths.
However, only 11 patients (33.3%) died due to cardio-
vascular causes in our study, although there were five
cases of death from unknown causes, which might have
included death due to undetected cardiovascular disease.
Furthermore, the follow-up period was relatively short in
our study, which might have resulted in an apparently
lower mortality rate.
Our data show that hemodialysis patients had a higher
mortality rate compared with those treated with peri-
toneal dialysis. The hemodialysis patients were also sig-
nificantly older than the peritoneal dialysis patients (mean
age: 56.1±14.3 vs. 44.4±13.1 yr, respectively; p<0.0001).
Diabetes significantly affected the survival rate of peri-
toneal dialysis patients overall, but it did not significantly
affect survival in the hemodialysis group (Fig. 4). Fewer
peritoneal dialysis patients developed end-stage renal
disease due to diabetes. Because diabetes is a major factor
in the development of cardiovascular disease, and fewer
peritoneal dialysis patients had cardiovascular disease, the
survival rates between the two modalities could not be
compared.
In subgroup analyses, lower mortality rates were
observed for early initiation of chronic dialysis in end-
stage renal disease among the hemodialysis patients,
whereas no differences were observed among the
peritoneal dialysis patients. In the hemodialysis group, 23
(21.3%) patients died; only 10 (9.8%) peritoneal dialysis
patients died. The lower mortality rate and small sample
size that was based on the eGFR at the start of dialysis
may underlie the lower mortality among the peritoneal
dialysis patients. In contrast to our findings, the CANUSA
study showed higher mortality in peritoneal dialysis
patients with lower creatinine clearance and a much lower
mortality rate for peritoneal dialysis patients than that
reported in our study. One possible reason for this
difference is the younger mean age of the patients in the
peritoneal dialysis group in our study (mean age: 54.3
vs. 44.4 yr, CANUSA study vs. our study). As age is an
important prognostic factor, it may explain the higher
mortality in the older patient group in the CANUSA study.
Moreover, no mortality based on the residual renal
function at the beginning of dialysis was observed in our
peritoneal dialysis patients.
In conclusion, this study fails to support the view that
early initiation of dialysis can prolong the survival of
patients with end-stage renal disease. Furthermore, there
were no differences in survival based on the indications
for initiation of dialysis. However, higher mortality rates
were observed for patients treated with hemodialysis
compared with peritoneal dialysis, and higher mortality
rates were observed for late initiation of treatment in
hemodialysis patients. Further research with a greater
sample size is required to verify whether early initiation of
treatment could improve survival among patients with
end-stage renal disease; this will be defined by the results
of the Initiating Dialysis Early and Late Study [11].
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